Clinical Trial Update: QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study

View source ↗

Summary

Completed clinical performance study evaluating the QIAstat-Dx BCID Plus AMR Panels for rapid identification of pathogens and antimicrobial resistance directly …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infection

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Blood Disease | Status: COMPLETED